| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sjogren's Syndrome | 21 | 2024 | 274 | 4.490 |
Why?
|
| Salivary Glands | 9 | 2024 | 58 | 2.320 |
Why?
|
| Antibodies, Antinuclear | 13 | 2023 | 183 | 1.990 |
Why?
|
| Lupus Erythematosus, Systemic | 13 | 2021 | 994 | 1.910 |
Why?
|
| Lupus Nephritis | 11 | 2015 | 103 | 1.850 |
Why?
|
| Mice | 51 | 2024 | 4802 | 1.410 |
Why?
|
| Autoimmune Diseases | 8 | 2020 | 166 | 1.340 |
Why?
|
| Immunity, Innate | 7 | 2023 | 231 | 1.330 |
Why?
|
| Disease Models, Animal | 18 | 2024 | 1507 | 1.260 |
Why?
|
| Immunoglobulin G | 10 | 2022 | 272 | 1.240 |
Why?
|
| Autoantibodies | 19 | 2023 | 481 | 1.230 |
Why?
|
| Antibodies, Bacterial | 2 | 2021 | 103 | 1.200 |
Why?
|
| Animals | 57 | 2024 | 10684 | 1.100 |
Why?
|
| Autoimmunity | 7 | 2017 | 158 | 1.020 |
Why?
|
| Inflammation | 9 | 2023 | 667 | 0.880 |
Why?
|
| Xerostomia | 2 | 2022 | 9 | 0.850 |
Why?
|
| Kidney Diseases | 4 | 2015 | 61 | 0.850 |
Why?
|
| Membrane Proteins | 3 | 2023 | 485 | 0.830 |
Why?
|
| Receptors, Cell Surface | 9 | 2002 | 114 | 0.800 |
Why?
|
| Mesangial Cells | 3 | 2012 | 9 | 0.800 |
Why?
|
| Inhibitor of Differentiation Proteins | 2 | 2014 | 11 | 0.790 |
Why?
|
| Dermatitis | 1 | 2023 | 7 | 0.780 |
Why?
|
| Glomerulonephritis | 3 | 2012 | 16 | 0.780 |
Why?
|
| Lymphocyte Activation | 6 | 2014 | 210 | 0.710 |
Why?
|
| Immunoglobulin A | 1 | 2021 | 23 | 0.700 |
Why?
|
| Enterococcus | 1 | 2021 | 19 | 0.690 |
Why?
|
| Kidney Glomerulus | 3 | 2010 | 15 | 0.690 |
Why?
|
| Sialadenitis | 5 | 2019 | 16 | 0.690 |
Why?
|
| Intestines | 2 | 2021 | 118 | 0.670 |
Why?
|
| Membrane Glycoproteins | 12 | 2016 | 149 | 0.660 |
Why?
|
| T-Lymphocytes | 9 | 2015 | 285 | 0.650 |
Why?
|
| Female | 45 | 2024 | 15624 | 0.650 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 138 | 0.600 |
Why?
|
| Periodontitis | 1 | 2018 | 11 | 0.570 |
Why?
|
| Egg Proteins | 10 | 2002 | 17 | 0.570 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 2018 | 18 | 0.570 |
Why?
|
| Ribonucleoproteins | 6 | 2018 | 154 | 0.540 |
Why?
|
| Submandibular Gland | 3 | 2015 | 11 | 0.500 |
Why?
|
| Kidney | 3 | 2013 | 289 | 0.500 |
Why?
|
| Mice, Knockout | 9 | 2024 | 874 | 0.500 |
Why?
|
| Mice, Inbred C57BL | 13 | 2024 | 1653 | 0.490 |
Why?
|
| Ovarian Diseases | 4 | 2002 | 7 | 0.430 |
Why?
|
| Aluminum | 1 | 2014 | 6 | 0.430 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 38 | 0.420 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2012 | 112 | 0.420 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2013 | 4 | 0.410 |
Why?
|
| Interferons | 3 | 2023 | 70 | 0.390 |
Why?
|
| Humans | 25 | 2023 | 28851 | 0.390 |
Why?
|
| Antigens | 1 | 2012 | 68 | 0.380 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 45 | 0.350 |
Why?
|
| Biomarkers | 4 | 2023 | 776 | 0.350 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2005 | 47 | 0.340 |
Why?
|
| Glomerular Mesangium | 1 | 2010 | 5 | 0.340 |
Why?
|
| Zona Pellucida | 6 | 1999 | 6 | 0.330 |
Why?
|
| Mitochondria | 2 | 2024 | 408 | 0.330 |
Why?
|
| Toll-Like Receptor 3 | 2 | 2011 | 17 | 0.320 |
Why?
|
| Genetic Therapy | 1 | 2011 | 124 | 0.320 |
Why?
|
| Mice, Inbred NZB | 5 | 2020 | 14 | 0.300 |
Why?
|
| Calcium Signaling | 2 | 2024 | 72 | 0.300 |
Why?
|
| Mice, Inbred Strains | 7 | 2018 | 61 | 0.300 |
Why?
|
| Integrin alpha Chains | 1 | 2008 | 4 | 0.300 |
Why?
|
| Thymectomy | 3 | 2005 | 4 | 0.290 |
Why?
|
| Cytokines | 5 | 2023 | 451 | 0.290 |
Why?
|
| Autoantigens | 6 | 2009 | 212 | 0.280 |
Why?
|
| Epitopes | 4 | 2018 | 185 | 0.280 |
Why?
|
| Salivation | 3 | 2019 | 11 | 0.280 |
Why?
|
| Antigen-Antibody Complex | 4 | 2013 | 19 | 0.280 |
Why?
|
| Sperm-Ovum Interactions | 5 | 1997 | 5 | 0.270 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2013 | 676 | 0.260 |
Why?
|
| Saliva | 4 | 2018 | 96 | 0.260 |
Why?
|
| Ovary | 6 | 2002 | 72 | 0.260 |
Why?
|
| Lymph Nodes | 2 | 2006 | 103 | 0.260 |
Why?
|
| Immunotherapy | 1 | 2008 | 163 | 0.260 |
Why?
|
| Renal Insufficiency | 1 | 2006 | 20 | 0.260 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2019 | 40 | 0.250 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2005 | 1 | 0.240 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2005 | 7 | 0.240 |
Why?
|
| Disease Progression | 4 | 2020 | 477 | 0.230 |
Why?
|
| Male | 19 | 2020 | 13921 | 0.220 |
Why?
|
| Anoctamin-1 | 1 | 2024 | 3 | 0.220 |
Why?
|
| Interferon Type I | 4 | 2020 | 56 | 0.220 |
Why?
|
| Oophoritis | 3 | 2005 | 3 | 0.220 |
Why?
|
| Zona Pellucida Glycoproteins | 9 | 2002 | 9 | 0.210 |
Why?
|
| Superoxide Dismutase | 1 | 2024 | 71 | 0.210 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2020 | 60 | 0.200 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2014 | 46 | 0.200 |
Why?
|
| Vimentin | 1 | 2023 | 28 | 0.200 |
Why?
|
| Signal Transduction | 5 | 2020 | 1469 | 0.190 |
Why?
|
| Rabbits | 2 | 2022 | 277 | 0.190 |
Why?
|
| Epithelial Cells | 1 | 2024 | 265 | 0.180 |
Why?
|
| Pilocarpine | 2 | 2014 | 8 | 0.180 |
Why?
|
| Muscarinic Agonists | 2 | 2014 | 9 | 0.180 |
Why?
|
| Dendritic Cells | 3 | 2019 | 143 | 0.180 |
Why?
|
| DNA | 5 | 2009 | 377 | 0.180 |
Why?
|
| Interleukin-6 | 3 | 2016 | 198 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 179 | 0.170 |
Why?
|
| Endothelial Cells | 2 | 2022 | 373 | 0.170 |
Why?
|
| Sarcoidosis | 1 | 2020 | 38 | 0.170 |
Why?
|
| Models, Animal | 1 | 2020 | 130 | 0.160 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 56 | 0.160 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 117 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2019 | 125 | 0.160 |
Why?
|
| Oxidative Stress | 1 | 2024 | 677 | 0.160 |
Why?
|
| Monocytes | 1 | 2020 | 135 | 0.160 |
Why?
|
| Th1 Cells | 1 | 1999 | 36 | 0.150 |
Why?
|
| Macrophage Activation | 2 | 2014 | 32 | 0.150 |
Why?
|
| Adjuvants, Immunologic | 3 | 2014 | 68 | 0.150 |
Why?
|
| Transcriptome | 1 | 2020 | 231 | 0.150 |
Why?
|
| Hyperglycemia | 1 | 2019 | 78 | 0.150 |
Why?
|
| Interferon Regulatory Factors | 1 | 2019 | 58 | 0.150 |
Why?
|
| Immunologic Memory | 1 | 2019 | 58 | 0.150 |
Why?
|
| Flow Cytometry | 3 | 2011 | 292 | 0.150 |
Why?
|
| Lacrimal Apparatus | 1 | 2018 | 3 | 0.150 |
Why?
|
| Influenza A virus | 1 | 2019 | 37 | 0.150 |
Why?
|
| Peptide Fragments | 3 | 1994 | 202 | 0.150 |
Why?
|
| Treponema denticola | 1 | 2018 | 6 | 0.140 |
Why?
|
| Porphyromonas gingivalis | 1 | 2018 | 7 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 98 | 0.140 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 465 | 0.140 |
Why?
|
| Toll-Like Receptor 7 | 2 | 2016 | 20 | 0.140 |
Why?
|
| Antibody Specificity | 4 | 2008 | 114 | 0.140 |
Why?
|
| Contraception, Immunologic | 2 | 1996 | 4 | 0.140 |
Why?
|
| Immunization, Passive | 2 | 2015 | 20 | 0.140 |
Why?
|
| Sex Factors | 3 | 2018 | 467 | 0.140 |
Why?
|
| Sialoglycoproteins | 1 | 2017 | 8 | 0.140 |
Why?
|
| Podocytes | 1 | 2017 | 13 | 0.140 |
Why?
|
| Galactosyltransferases | 1 | 2017 | 17 | 0.130 |
Why?
|
| Mucins | 1 | 2017 | 25 | 0.130 |
Why?
|
| Mice, Inbred NOD | 3 | 2019 | 50 | 0.130 |
Why?
|
| Gene Expression | 2 | 2018 | 417 | 0.130 |
Why?
|
| Contraceptive Agents | 1 | 1997 | 8 | 0.130 |
Why?
|
| Polysaccharides | 1 | 2017 | 64 | 0.130 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2015 | 30 | 0.130 |
Why?
|
| Swine | 4 | 1993 | 238 | 0.130 |
Why?
|
| Vaccines | 1 | 1997 | 35 | 0.130 |
Why?
|
| Receptor, Interferon alpha-beta | 2 | 2013 | 7 | 0.120 |
Why?
|
| Alleles | 2 | 2015 | 354 | 0.120 |
Why?
|
| STAT1 Transcription Factor | 1 | 2016 | 38 | 0.120 |
Why?
|
| Antibodies | 3 | 2008 | 125 | 0.120 |
Why?
|
| Poly I-C | 3 | 2012 | 13 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2018 | 897 | 0.120 |
Why?
|
| Prostatitis | 2 | 2005 | 4 | 0.120 |
Why?
|
| src-Family Kinases | 1 | 2015 | 71 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 3 | 1993 | 336 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 163 | 0.110 |
Why?
|
| Chorionic Gonadotropin | 1 | 1994 | 22 | 0.110 |
Why?
|
| Interferon-gamma | 3 | 2020 | 108 | 0.110 |
Why?
|
| Antibody Formation | 2 | 2007 | 77 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2011 | 513 | 0.110 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2015 | 42 | 0.110 |
Why?
|
| Retrospective Studies | 1 | 2021 | 2635 | 0.110 |
Why?
|
| Carrier Proteins | 1 | 2016 | 255 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 465 | 0.110 |
Why?
|
| Pneumonia | 1 | 2015 | 89 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2014 | 58 | 0.110 |
Why?
|
| Molecular Mimicry | 1 | 2014 | 30 | 0.100 |
Why?
|
| Ovarian Follicle | 1 | 1994 | 84 | 0.100 |
Why?
|
| Peptides | 3 | 2014 | 296 | 0.100 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 3 | 2009 | 41 | 0.100 |
Why?
|
| Progesterone | 1 | 1994 | 130 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2009 | 251 | 0.100 |
Why?
|
| Immune Tolerance | 2 | 2005 | 52 | 0.100 |
Why?
|
| Apoptosis | 3 | 2020 | 780 | 0.100 |
Why?
|
| Lung | 4 | 2020 | 382 | 0.100 |
Why?
|
| Epitopes, B-Lymphocyte | 2 | 2007 | 24 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2018 | 257 | 0.090 |
Why?
|
| Lipids | 2 | 2011 | 218 | 0.090 |
Why?
|
| Cell Line | 1 | 2014 | 700 | 0.090 |
Why?
|
| Organ Specificity | 2 | 2020 | 82 | 0.090 |
Why?
|
| Cross Reactions | 4 | 2014 | 74 | 0.090 |
Why?
|
| Immunization | 3 | 2018 | 121 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 634 | 0.090 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2011 | 14 | 0.090 |
Why?
|
| Microscopy, Electron | 1 | 2011 | 94 | 0.090 |
Why?
|
| Immune System | 1 | 2011 | 29 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 328 | 0.090 |
Why?
|
| Proteins | 1 | 2013 | 254 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2011 | 140 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2014 | 523 | 0.080 |
Why?
|
| Acute Disease | 2 | 2013 | 155 | 0.080 |
Why?
|
| Atherosclerosis | 1 | 2011 | 97 | 0.080 |
Why?
|
| HLA-DQ Antigens | 1 | 2009 | 25 | 0.080 |
Why?
|
| HLA-DR Antigens | 1 | 2009 | 29 | 0.080 |
Why?
|
| Macaca fascicularis | 2 | 2002 | 45 | 0.080 |
Why?
|
| Genetic Complementation Test | 1 | 2009 | 24 | 0.080 |
Why?
|
| Xanthones | 2 | 2020 | 6 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2010 | 137 | 0.080 |
Why?
|
| Secretory Rate | 1 | 2009 | 5 | 0.070 |
Why?
|
| Interferon Inducers | 1 | 2009 | 3 | 0.070 |
Why?
|
| Salivary Ducts | 1 | 2009 | 3 | 0.070 |
Why?
|
| Chemokine CCL5 | 1 | 2009 | 4 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 66 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2009 | 46 | 0.070 |
Why?
|
| Immunophenotyping | 2 | 2020 | 61 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 270 | 0.070 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 236 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2009 | 247 | 0.070 |
Why?
|
| Liposomes | 1 | 2008 | 145 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 465 | 0.070 |
Why?
|
| Estrus | 2 | 1999 | 23 | 0.070 |
Why?
|
| Rats | 1 | 2010 | 1588 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 114 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2006 | 61 | 0.060 |
Why?
|
| Host-Pathogen Interactions | 2 | 2019 | 92 | 0.060 |
Why?
|
| Immunoprecipitation | 2 | 2017 | 68 | 0.060 |
Why?
|
| Risk Factors | 1 | 2011 | 2126 | 0.060 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2005 | 1 | 0.060 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2005 | 5 | 0.060 |
Why?
|
| fas Receptor | 1 | 2005 | 19 | 0.060 |
Why?
|
| Receptors, Interleukin | 1 | 2005 | 12 | 0.060 |
Why?
|
| Hematopoiesis | 1 | 2005 | 25 | 0.060 |
Why?
|
| Epitope Mapping | 3 | 2018 | 38 | 0.060 |
Why?
|
| Macrophages | 2 | 2013 | 305 | 0.060 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 133 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2005 | 274 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2014 | 697 | 0.050 |
Why?
|
| Lymphocyte Count | 2 | 2019 | 15 | 0.050 |
Why?
|
| Self Tolerance | 1 | 2004 | 9 | 0.050 |
Why?
|
| Nucleosomes | 1 | 2004 | 18 | 0.050 |
Why?
|
| Phenotype | 2 | 2016 | 685 | 0.050 |
Why?
|
| Calcium | 1 | 2024 | 243 | 0.050 |
Why?
|
| Age Factors | 1 | 2005 | 737 | 0.050 |
Why?
|
| Th2 Cells | 1 | 2002 | 15 | 0.050 |
Why?
|
| Complement C3 | 1 | 2002 | 21 | 0.050 |
Why?
|
| HLA-DR3 Antigen | 2 | 2014 | 10 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2002 | 182 | 0.050 |
Why?
|
| Mice, Inbred MRL lpr | 2 | 2015 | 7 | 0.040 |
Why?
|
| Clonal Anergy | 1 | 2020 | 11 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2020 | 84 | 0.040 |
Why?
|
| B-Lymphocytes | 2 | 2016 | 285 | 0.040 |
Why?
|
| Middle Aged | 3 | 2017 | 7414 | 0.040 |
Why?
|
| Chemokines | 1 | 2020 | 74 | 0.040 |
Why?
|
| Dacryocystitis | 2 | 2013 | 5 | 0.040 |
Why?
|
| Mice, Inbred A | 1 | 1999 | 14 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 1999 | 23 | 0.040 |
Why?
|
| Infertility, Female | 1 | 1999 | 43 | 0.040 |
Why?
|
| Cell Movement | 1 | 2020 | 376 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 739 | 0.040 |
Why?
|
| snRNP Core Proteins | 2 | 2009 | 33 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 3 | 1993 | 278 | 0.040 |
Why?
|
| Models, Biological | 1 | 2020 | 469 | 0.040 |
Why?
|
| Cytosol | 1 | 2018 | 49 | 0.030 |
Why?
|
| Protein Domains | 1 | 2018 | 53 | 0.030 |
Why?
|
| Spleen | 2 | 2015 | 113 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2017 | 24 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2017 | 19 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 1999 | 668 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1997 | 50 | 0.030 |
Why?
|
| Hypergammaglobulinemia | 1 | 2016 | 7 | 0.030 |
Why?
|
| Tripartite Motif Proteins | 1 | 2016 | 8 | 0.030 |
Why?
|
| Sulfur Radioisotopes | 1 | 2016 | 10 | 0.030 |
Why?
|
| Rheumatoid Factor | 1 | 2016 | 28 | 0.030 |
Why?
|
| Vaccines, Synthetic | 1 | 1996 | 9 | 0.030 |
Why?
|
| Methionine | 1 | 2016 | 38 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1997 | 233 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 72 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 485 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 1996 | 1056 | 0.030 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2015 | 10 | 0.030 |
Why?
|
| Syndecan-1 | 1 | 2015 | 13 | 0.030 |
Why?
|
| Heterozygote | 1 | 2015 | 69 | 0.030 |
Why?
|
| Splenomegaly | 1 | 2015 | 10 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2015 | 12 | 0.030 |
Why?
|
| Viral Matrix Proteins | 1 | 2015 | 6 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2015 | 28 | 0.030 |
Why?
|
| Models, Immunological | 2 | 2005 | 22 | 0.030 |
Why?
|
| Macaca radiata | 1 | 1994 | 1 | 0.030 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 1994 | 8 | 0.030 |
Why?
|
| Biopsy | 1 | 2015 | 208 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2015 | 80 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 787 | 0.030 |
Why?
|
| Capnocytophaga | 1 | 2014 | 2 | 0.030 |
Why?
|
| Hybridomas | 1 | 2014 | 17 | 0.030 |
Why?
|
| Fertility | 1 | 1994 | 60 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 461 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1993 | 62 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2014 | 36 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2013 | 6 | 0.030 |
Why?
|
| Mouth | 1 | 2014 | 31 | 0.030 |
Why?
|
| Vagina | 1 | 2014 | 42 | 0.030 |
Why?
|
| Vacuoles | 1 | 2013 | 11 | 0.030 |
Why?
|
| Proteinuria | 1 | 2013 | 14 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1993 | 133 | 0.030 |
Why?
|
| Adult | 2 | 2017 | 8024 | 0.030 |
Why?
|
| Immunity | 1 | 2013 | 27 | 0.030 |
Why?
|
| Capillaries | 1 | 2013 | 33 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1993 | 242 | 0.030 |
Why?
|
| Species Specificity | 1 | 1993 | 194 | 0.030 |
Why?
|
| Sheep | 1 | 2013 | 100 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2016 | 1022 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2013 | 74 | 0.020 |
Why?
|
| Endocytosis | 1 | 2013 | 96 | 0.020 |
Why?
|
| Skin | 1 | 2014 | 152 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 416 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 555 | 0.020 |
Why?
|
| Spermatozoa | 1 | 1992 | 34 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2012 | 35 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1993 | 258 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2012 | 58 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2012 | 52 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2012 | 74 | 0.020 |
Why?
|
| Submandibular Gland Diseases | 1 | 2011 | 2 | 0.020 |
Why?
|
| Chemokine CCL7 | 1 | 2011 | 3 | 0.020 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2011 | 4 | 0.020 |
Why?
|
| Chemokine CCL4 | 1 | 2011 | 3 | 0.020 |
Why?
|
| Chemokine CCL11 | 1 | 2011 | 4 | 0.020 |
Why?
|
| Chemokine CXCL13 | 1 | 2011 | 7 | 0.020 |
Why?
|
| Chemokines, CXC | 1 | 2011 | 12 | 0.020 |
Why?
|
| Chemokine CCL3 | 1 | 2011 | 9 | 0.020 |
Why?
|
| Chemokines, CC | 1 | 2011 | 6 | 0.020 |
Why?
|
| Chemokine CXCL10 | 1 | 2011 | 22 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2011 | 47 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2011 | 65 | 0.020 |
Why?
|
| Antibody Diversity | 1 | 2009 | 5 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2009 | 22 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2008 | 8 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 2833 | 0.020 |
Why?
|
| IgG Deficiency | 1 | 2005 | 1 | 0.010 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2005 | 10 | 0.010 |
Why?
|
| Lymphopenia | 1 | 2005 | 8 | 0.010 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2005 | 6 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2005 | 24 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 81 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2005 | 288 | 0.010 |
Why?
|
| Colon | 1 | 2005 | 123 | 0.010 |
Why?
|
| Animals, Congenic | 1 | 2004 | 2 | 0.010 |
Why?
|
| Longevity | 1 | 2005 | 141 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2004 | 138 | 0.010 |
Why?
|
| Transplants | 1 | 2002 | 3 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2005 | 427 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2002 | 53 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1993 | 124 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 169 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1992 | 66 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1992 | 50 | 0.010 |
Why?
|